Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant
Clinical trial NCT05222438 · WITHDRAWN
Trial details
- NCT number
- NCT05222438
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-08
- Primary completion
- 2025-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.